Literature DB >> 17586097

Conversions between monotherapies in epilepsy: expert consensus.

Erik K St Louis1, Barry E Gidal, Thomas R Henry, Yevgenya Kaydanova, Allan Krumholz, Paul H McCabe, Georgia D Montouris, William E Rosenfeld, Brien J Smith, John M Stern, Elizabeth J Waterhouse, Richard M Schulz, William R Garnett, Thomas Bramley.   

Abstract

To develop expert consensus for conversion between antiepileptic drug (AED) monotherapies, an 11-member panel used the Delphi Technique over three rounds to: (1) identify relevant issues, (2) vote on the issues, and (3) develop consensus. The panel agreed on the basic principle to taper the existing AED only after a presumably efficacious dose of the planned AED was reached. Application is modified by adverse effects possibly attributable to the existing drug, in which case earlier or more rapid tapering of the existing drug should be considered. Patients with uncontrolled seizures, as well as seizure-free patients for whom driving privileges are a consideration, may benefit from slower tapering by smaller dosage decrements of the existing AED. For 10 of the 12 AEDs considered, the panel made titration recommendations concerning initial and target doses for the planned AED, supplementing limited data in the prescribing information. This expert guidance will aid in the period of transitional polytherapy with AEDs from monotherapy to monotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586097     DOI: 10.1016/j.yebeh.2007.04.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  12 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.

Authors:  Erik K St Louis
Journal:  Pharmaceuticals (Basel)       Date:  2010-09-01

Review 3.  New-onset epilepsy in the elderly.

Authors:  Lily Chi Vu; Loretta Piccenna; Patrick Kwan; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2018-07-28       Impact factor: 4.335

4.  Magic Moments: Determinants of Stress Relief and Subjective Wellbeing from Visiting a Cultural Heritage Site.

Authors:  Enzo Grossi; Giorgio Tavano Blessi; Pier Luigi Sacco
Journal:  Cult Med Psychiatry       Date:  2019-03

5.  Modeling costs and outcomes associated with a treatment algorithm for problem bleeding episodes in patients with severe hemophilia a and high-titer inhibitors.

Authors:  Patrick Bonnet; Alessandro Gringeri; Edward Gomperts; Cindy Anne Leissinger; Roseline d'Oiron; Jerome Teitel; Guy Young; Meg Franklin; Bruce Ewenstein; Erik Berntorp
Journal:  Am Health Drug Benefits       Date:  2011-07

6.  Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.

Authors:  William R Garnett; Erik K St Louis; Thomas R Henry; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

7.  Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.

Authors:  Erik K St Louis; Erik K Louis
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

8.  Monotherapy to polytherapy: antiepileptic drug conversions through the spectrum of epilepsy care.

Authors:  Erik K St Louis
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

9.  Antiepileptic drug monotherapy: the initial approach in epilepsy management.

Authors:  Erik K St Louis; William E Rosenfeld; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

10.  Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.

Authors:  Erik K St Louis
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.